Efficient (18)F-Labeling of Synthetic Exendin-4 Analogues for Imaging Beta Cells

por Keliher, Edmund J, Reiner, Thomas, Thurber, Greg M, Upadhyay, Rabi, Weissleder, Ralph
Publicado 2012

Rapid, high efficiency isolation of pancreatic ß-cells

por Clardy, Susan M., Mohan, James F., Vinegoni, Claudio, Keliher, Edmund J., Iwamoto, Yoshiko, Benoist, Christophe, Mathis, Diane, Weissleder, Ralph
Publicado 2015

In Vivo Imaging of GLP-1R with a Targeted Bimodal PET/Fluorescence Imaging Agent

por Brand, Christian, Abdel-Atti, Dalya, Zhang, Yachao, Carlin, Sean, Clardy, Susan M., Keliher, Edmund J., Weber, Wolfgang A., Lewis, Jason S., Reiner, Thomas
Publicado 2014

Myeloperoxidase PET Imaging Tracks Intracellular and Extracellular Treatment Changes in Experimental Myocardial Infarction

por Zeller, Matthias W. G., Wang, Cuihua, Keliher, Edmund J., Wojtkiewicz, Gregory R., Aguirre, Aaron, Maresca, Kevin, Su, Chunyan, Buckbinder, Leonard, Wang, Jing, Nahrendorf, Matthias, Chen, John W.
Publicado 2023

Noninvasive imaging of immune responses

por Rashidian, Mohammad, Keliher, Edmund J., Bilate, Angelina M., Duarte, Joao N., Wojtkiewicz, Gregory R., Jacobsen, Johanne Tracey, Cragnolini, Juanjo, Swee, Lee Kim, Victora, Gabriel D., Weissleder, Ralph, Ploegh, Hidde L.
Publicado 2015

Use of (18)F-2-Fluorodeoxyglucose to Label Antibody Fragments for Immuno-Positron Emission Tomography of Pancreatic Cancer

por Rashidian, Mohammad, Keliher, Edmund J., Dougan, Michael, Juras, Patrick K., Cavallari, Marco, Wojtkiewicz, Gregory R., Jacobsen, Johanne T., Edens, Jerre G., Tas, Jeroen M. J., Victora, Gabriel, Weissleder, Ralph, Ploegh, Hidde
Publicado 2015

PD-L1 is an activation-independent marker of brown adipocytes

por Ingram, Jessica R., Dougan, Michael, Rashidian, Mohammad, Knoll, Marko, Keliher, Edmund J., Garrett, Sarah, Garforth, Scott, Blomberg, Olga S., Espinosa, Camilo, Bhan, Atul, Almo, Steven C., Weissleder, Ralph, Lodish, Harvey, Dougan, Stephanie K., Ploegh, Hidde L.
Publicado 2017

Myeloperoxidase inhibition in mice alters atherosclerotic lesion composition

por Roth Flach, Rachel J., Su, Chunyan, Bollinger, Eliza, Cortes, Christian, Robertson, Andrew W., Opsahl, Alan C., Coskran, Timothy M., Maresca, Kevin P., Keliher, Edmund J., Yates, Phillip D., Kim, Albert M., Kalgutkar, Amit S., Buckbinder, Leonard
Publicado 2019

Anti–CTLA-4 therapy requires an Fc domain for efficacy

por Ingram, Jessica R., Blomberg, Olga S., Rashidian, Mohammad, Ali, Lestat, Garforth, Scott, Fedorov, Elena, Fedorov, Alexander A., Bonanno, Jeffrey B., Le Gall, Camille, Crowley, Stephanie, Espinosa, Camilo, Biary, Tamara, Keliher, Edmund J., Weissleder, Ralph, Almo, Steven C., Dougan, Stephanie K., Ploegh, Hidde L., Dougan, Michael
Publicado 2018

Target occupancy study and whole-body dosimetry with a MAGL PET ligand [(11)C]PF-06809247 in non-human primates

por Arakawa, Ryosuke, Takano, Akihiro, Nag, Sangram, Jia, Zhisheng, Amini, Nahid, Maresca, Kevin P., Zhang, Lei, Keliher, Edmund J., Butler, Christopher R., Piro, Justin R., Samad, Tarek A., Smith, Deborah, Nason, Deane, O’Neil, Steve, Trapa, Patrick, Fonseca, Kari R., Litchfield, John, McCarthy, Timothy, Carson, Richard E., Halldin, Christer
Publicado 2022

Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease

por Keliher, Edmund J., Ye, Yu-Xiang, Wojtkiewicz, Gregory R., Aguirre, Aaron D., Tricot, Benoit, Senders, Max L., Groenen, Hannah, Fay, Francois, Perez-Medina, Carlos, Calcagno, Claudia, Carlucci, Giuseppe, Reiner, Thomas, Sun, Yuan, Courties, Gabriel, Iwamoto, Yoshiko, Kim, Hye-Yeong, Wang, Cuihua, Chen, John W., Swirski, Filip K., Wey, Hsiao-Ying, Hooker, Jacob, Fayad, Zahi A., Mulder, Willem J. M., Weissleder, Ralph, Nahrendorf, Matthias
Publicado 2017